Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Equity Ratio (2016 - 2025)

AC Immune has reported Equity Ratio over the past 11 years, most recently at 0.29 for Q4 2025.

  • Quarterly Equity Ratio fell 40.15% to 0.29 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.29 through Dec 2025, down 40.15% year-over-year, with the annual reading at 0.29 for FY2025, 40.15% down from the prior year.
  • Equity Ratio was 0.29 for Q4 2025 at AC Immune, down from 0.36 in the prior quarter.
  • Over five years, Equity Ratio peaked at 909882.92 in Q1 2021 and troughed at 0.29 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.88 (2021), against an average of 134386.34.
  • Year-over-year, Equity Ratio soared 98741009.07% in 2021 and then plummeted 100.0% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.89 in 2021, then grew by 2.43% to 0.91 in 2022, then fell by 3.32% to 0.88 in 2023, then plummeted by 44.67% to 0.49 in 2024, then crashed by 40.15% to 0.29 in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Equity Ratio are 0.29 (Q4 2025), 0.36 (Q3 2025), and 0.39 (Q2 2025).